Friday, March 27, 2015
Biotech giant Genentech plans to invest more than $125 million to expand its fill/finish production facility in Hillsboro, resulting in up to 100 new skilled manufacturing jobs, the company announced.
The investment in sterile production operations will bring the total number of Genentech jobs in Oregon to more than 500 over the next five years, Larry Sanders, Genentech general manager and vice president of Hillsboro Technical Operations, said in a statement.
“This announcement is another indicator that this is an exciting time in Oregon’s history,” Gov. Kate Brown said in a statement. “Genentech’s investment in its Hillsboro campus and Oregon’s robust workforce underscore that Oregon is a great place for all businesses to build their future and for the biotech sector to grow.”
Genentech opened its Hillsboro plant in April 2010 as part of the company’s strategy to increase manufacturing capacity.
Genentech, which is headquartered in South San Francisco, is a unit of Swiss drug-maker Roche.
bizjournals.com
